The Impact of Tumour Characteristics on Hereditary Breast Cancer Screening

作者: Madeleine Tilanus-Linthorst

DOI:

关键词: PregnancyInternal medicineCancerDiseaseMenopauseRisk factors for breast cancerBreast cancerGynecologyMedicineFamily historyIncidence (epidemiology)Oncology

摘要: textabstractIn the Western world breast cancer is a fairly common disease in women, nearly one in ten diagnosed with during her life. Worldwide 1.200.000 women are diagnosed with annually, Netherlands about 12.000, 25% of them before age 50 years 1. incidence doubled between 1975 and 2000, steepest increase developing countries. Survival has clearly improved last decade, mainly as result earlier detection by women’s awareness mammography screening, and also increased use adjuvant hormonal chemotherapy 2,3. The diagnosis still frightening as approximately 3.500 die annually metastases the Netherlands, but an increasing number survives after disease. The main risk factors for associated with; age, family history previous cancer. Only small fraction, 20%, all breast deaths western worldwide estimated to be caused by preventable behavioural risk-factors like physical inactivity, obesity, alcohol consumption and replacement therapy (HRT) 4. These influence hormonal balance, leading instance early menarche late menopause, that are known increase risk. Like postmenopausal replacement therapy, nulliparity, harmful effect seems cumulative exposure ovarian hormones/ ovulatory cycles. While also preventive prolonged breast-feeding may reduced cycles, protective first full-term pregnancy at relatively young age terminal differentiation the breast epithelium. cycles and the decrease explained their on the cell divisions epithelial cells accumulation molecular and DNA damage.

参考文章(43)
Diana Eccles, Peter Simmonds, Jonathan Goddard, Marie Coultas, Shirley Hodgson, Fiona Lalloo, Gareth Evans, Neva Haites, None, Familial breast cancer: an investigation into the outcome of treatment for early stage disease. Familial Cancer. ,vol. 1, pp. 65- 72 ,(2001) , 10.1023/A:1013867917101
C. Seynaeve, C.T. M. Brekelmans, L.C. Verhoog, E.J. Meijers-Heijboer, E.M. J. J. Berns, J.G. M. Klijn, Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients. Journal of Clinical Oncology. ,vol. 18, ,(2000)
Hannaleena Eerola, Päivi Heikkilä, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist, Heli Nevanlinna, Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families Breast Cancer Research. ,vol. 7, pp. 1- 5 ,(2005) , 10.1186/BCR1025
Kelly-Anne Phillips, Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. Journal of Clinical Oncology. ,vol. 18, ,(2000)
L. C. Verhoog, C.T.M. Brekelmans, C. Seynaeve, G. Dahmen, A. N. van Geel, C.C.M. Bartels, M.M.A. Tilanus-Linthorst, A. Wagner, P. Devilee, D.J.J. Halley, A.M.W. van den Ouweland, E. J. Meijers-Heijboer, J.G.M. Klijn, Survival in Hereditary Breast Cancer Associated With Germline Mutations of BRCA2 Journal of Clinical Oncology. ,vol. 17, pp. 3396- 3402 ,(1999) , 10.1200/JCO.1999.17.11.3396
Douglas F. Easton, Fiona E. Matthews, Deborah Ford, Anthony J. Swerdlow, Julian Peto, Cancer mortality in relatives of women with ovarian cancer: The OPCS study International Journal of Cancer. ,vol. 65, pp. 284- 294 ,(1996) , 10.1002/(SICI)1097-0215(19960126)65:3<284::AID-IJC2>3.0.CO;2-W
Kathleen E. Malone, Janet R. Daling, Noel S. Weiss, Barbara McKnight, Emily White, Lynda F. Voigt, Family history and survival of young women with invasive breast carcinoma Cancer. ,vol. 78, pp. 1417- 1425 ,(1996) , 10.1002/(SICI)1097-0142(19961001)78:7<1417::AID-CNCR7>3.0.CO;2-H
Deepa S. Subramaniam, Claudine Isaacs, Utilizing prognostic and predictive factors in breast cancer. Current Treatment Options in Oncology. ,vol. 6, pp. 147- 159 ,(2005) , 10.1007/S11864-005-0022-1
L.C. Verhoog, A.M.W. van den Ouweland, E. Berns, M.M. van Veghel-Plandsoen, I.L. van Staveren, A. Wagner, C.C.M. Bartels, M.M.A. Tilanus-Linthorst, P. Devilee, C. Seynaeve, D.J.J. Halley, M.F. Niermeijer, J.G.M. Klijn, H. Meijers-Heijboer, Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families European Journal of Cancer. ,vol. 37, pp. 2082- 2090 ,(2001) , 10.1016/S0959-8049(01)00244-1
Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan GM Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine MA Tilanus, Carina CM Bartels, Leon C Verhoog, Cecile TM Brekelmans, Curt W Burger, Martinus F Niermeijer, One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery) Breast Cancer Research and Treatment. ,vol. 73, pp. 97- 112 ,(2002) , 10.1023/A:1015269620265